Cannabis & Biotech. Nuff Said.
Get ready to light up the conversation with finance expert Seth Yakatan as he spills the tea on the cannabis and biotech industries. Despite cannabis interest being at an all time high, the industry needs to weed out a ton of regulatory and technical hurdles. Join in as Seth shares how biotech is shaking things up in the cannabis world, from production to consumer goods. They'll also explore clinical trials and synthetic compounds, and highlight innovative companies and products. Get in the weeds on the future of bioengineering cannabis, and toke up some valuable insights.
Click here to read the episode transcript.
Topics Covered:
00:00:00 The Biology of Climate Change
00:01:06 Mild NYC Winter: Climate Change?
00:04:24 California and NY Legalize Cannabis
00:05:52 Life Sciences: A Family Influence
00:08:41 The Endocannabinoid System and Homeostasis
00:11:13 Epidiolex: Treating Epilepsy with Cannabis
00:13:59 Constraints in Cannabis Pharmaceutical Development
00:18:50 Tikkun Olam's Vehicle Strain: Phase Zero Testing
00:23:31 Constraints of the Cannabis Market
00:28:40 Synthetic Cannabis Production Attempts Fail
00:32:01 Exploring Compounds for Alternative Effects
00:36:44 Federal Change on Alcohol and Cannabis Regulation
00:41:19 Biotechnology and Cannabis: Novel Form Factors
00:43:07 Limited Capital for Biotech Companies
00:45:22 Biotech and Cannabis: Similarities and Opportunities
00:47:00 High-Quality Greenhouse Flower Production Profits
00:50:41 Investment in Canadian Cannabis by Pharmaceuticals and Tobacco
00:52:46 Consolidation in the Cannabis Beverage Industry
00:57:27 Factors in Industrial Cannabis Growth
00:59:29 Plant Engineering for Flavor Enhancement
01:02:26 Synthetic Biology and Cannabis Farming
01:07:17 Exploring Biotech Possibilities with Seth
Episode Links:
Seth on LinkedIn
